세계의 정형외과 기기 시장 : 제품별, 수술 건수별, 부위별, 용도별, 최종사용자별 - 예측(-2030년)

The global orthopedic devices market is expected to reach 68.51 billion by 2030 from USD 51.61 billion in 2024, at a CAGR of 4.8% from 2024 to 2030. The orthopedic devices market is growing due to increasing cases of musculoskeletal disorders, increasing geriatric population, and rising demand for minimally invasive surgical techniques. Osteoarthritis, rheumatoid arthritis, and osteoporosis are increasingly prevalent, especially among the elderly, and are increasing the need for joint replacement and fracture fixation equipment. Adoption of 3D printing, robotic-assisted surgery, and bioresorbable & smart implants, are improving patient outcomes. Osteoarthritis, rheumatoid arthritis, and osteoporosis are highly prevalent, especially among the elderly, and are driving demand for joint replacement and fracture fixation devices.

"The joint replacement devices segment to hold the largest share of the market in 2023."

Joint replacement devices are devices implanted to substitute diseased or damaged joints, mainly in the hip, knee, and shoulder, to decrease pain and enhance movement. They are driven by increasing obesity, which results in joint decay, and by more young people requiring early intervention. Technologies such as real-time tracking smart implants and personalized 3D-printed implants are improving surgical precision and patient recovery. Additionally, an increase in healthcare expenditure, supportive reimbursement policies, and government strategies enhance orthopedic care.

"The knee & thigh segment to hold the largest share of the market in 2023."

The knee & thigh segment accounts for the largest share of the orthopedic devices market by site due to the high incidence of fractures in knee, osteoarthritis, and osteoporosis. Knee replacement surgeries are the most common orthopedic procedures conducted, fueled by rising life expectancy and the increasing number of populations affected with degenerative joint diseases. Moreover, innovations in implant materials, minimally invasive surgical procedures, and robotic-assisted surgeries have improved the quality of life of patients. The increasing prevalence of sports injuries also drives the requirement for knee & thigh implants.

"The hospitals and surgical centers segment to hold the largest share of the market in 2023."

The segment of hospitals and surgical centers has the highest market share in orthopedic devices because they play a pivotal role in delivering high-end and specialized treatments for orthopedic conditions in patients. They provide technologically advanced orthopedic procedures, such as joint replacements and fracture fixations, which make them the first choices for orthopedic procedures. Also, hospitals and surgery centers usually possess the necessary funds to manage complicated cases, conduct minimally invasive procedures, and administer post-procedure treatment, all of which sustain demand for orthopedic devices.

"The market in the APAC region is expected to register the highest growth rate for orthopedic devices in 2023."

The orthopedic devices market covers five key geographies-North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2023, a significant market share for orthopedic devices was held by the market in the North American region, comprising the US and Canada. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period.

The Asia Pacific is experiencing the most rapid growth in the market for orthopedic devices due to a combination of factors such as a rapidly growing elderly population, increased disposable incomes, and growth in access to healthcare. The growth in musculoskeletal disorders such as arthritis and osteoporosis, particularly in countries such as Japan, China, and India, is driving the adoption of orthopedic treatments. Furthermore, the region is also experiencing a boost in health care infrastructure as well as new-age technology applications, such as minimally invasive procedures and robotic-assisted surgeries, that are improving surgical outcomes. Additionally, rising medical tourism in countries such as India and Thailand, along with government actions to enhance the health care infrastructure, is also contributing to growth in the market in the region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1- 30%, Tier 2- 42%, and Tier 3- 28%
• By Designation: Directors- 10%, Managers- 14%, and Others- 76%
• By Region: North America- 40%, Europe- 30%, Asia Pacific- 22%, Latin America- 6%, MEA- 2%

The prominent players in the Orthopedic devices market are Stryker Corporation (United States), Johnson & Johnson (United States), Globus Medical, Inc. (United States), Medacta International SA (Switzerland), Zimmer Biomet Holdings, Inc. (United States), Arthrex, Inc. (United States), Acumed LLC (United States), Enovis Corporation (United States), CONMED Corporation (United States), B. Braun Melsungen AG (Germany), Meril Life Sciences Pvt. Ltd. (India), (Ireland), Paragon 28, Inc. (United States), Smith & Nephew plc (United Kingdom), Orthofix Medical Inc. (United States).

Research Coverage

This market research report analyzes the orthopedic devices market along several different segments, such as product type, application, end-user, region, site and geography. The report further sheds light on market growth-driving factors, mentions opportunities and threats, and presents analysis of competitive rivalry of leading companies. It further studies micro markets by focusing on growth tendencies and predicts revenues for industry segments for five leading geographies, along with corresponding countries.

Reasons to Buy the Report

The report would assist both small and new businesses in comprehending the market pattern, which can help them grow their market place. Businesses procuring the report can implement any one or several of the approaches discussed to extend their market position.

This report provides insights on the following pointers:

• Key drivers (increasing requirement for minimally invasive orthopedic surgical procedures and increasing number of sports injuries, increasing incidence of orthopedic diseases and disorders and increasing research funding and restraints (risk and complications of orthopedic surgical procedures, exorbitant cost of orthopedic treatments, reduced reimbursements for orthopedic surgical procedures), opportunities (increasing number of hospitals and trend towards outpatient care, innovations in robotic-assisted orthopedic surgeries and 3D printing), and challenges (skilled orthopedic surgeons shortages) fueling the market growth of orthopedic devices
• Product Development/Innovation: In-depth study of emerging technologies, research & development programs, and new product & service launches in the orthopedic devices market
• Market Growth: In-depth insights into remunerative markets report analyzes the orthopedic devices market across varied geographies.
• Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the orthopedic devices market
• Competitive Analysis: In-depth analysis of market shares, growth strategies, and services of leading players, such as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS CONSIDERED AND REGIONS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 STAKEHOLDERS
• 1.4 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH DESIGN
  • 2.2.1 SECONDARY RESEARCH
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY RESEARCH
    • 2.2.2.1 Primary sources
    • 2.2.2.2 Key industry insights
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Approach 1: Company revenue estimation approach
    • 2.3.1.2 Approach 2: Customer-based market estimation
    • 2.3.1.3 Approach 3: Top-down approach
    • 2.3.1.4 Approach 4: Primary interviews
• 2.4 GROWTH FORECAST
• 2.5 DATA TRIANGULATION AND MARKET BREAKDOWN
• 2.6 MARKET SHARE ASSESSMENT
• 2.7 RESEARCH ASSUMPTIONS & LIMITATIONS
  • 2.7.1 ASSUMPTIONS
  • 2.7.2 LIMITATIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ORTHOPEDIC DEVICES MARKET OVERVIEW
• 4.2 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT
• 4.3 EUROPE: ORTHOPEDIC DEVICES MARKET, BY SITE
• 4.4 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY END USER (USD MILLION)
• 4.5 ORTHOPEDIC DEVICES MARKET, BY REGION

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising cases of orthopedic diseases and disorders
    • 5.2.1.2 Increasing adoption of telemedicine and telesurgery
    • 5.2.1.3 Increasing demand for minimally invasive orthopedic surgical procedures
    • 5.2.1.4 Growing number of sports and accident-related orthopedic injuries
    • 5.2.1.5 Rising geriatric population and projected increase in age-related bone disorders
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Risks and complications associated with orthopedic surgical procedures
    • 5.2.2.2 High cost of orthopedic devices and treatments
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing focus on orthobiologics
    • 5.2.3.2 Rising number of hospitals and shift toward outpatient care
    • 5.2.3.3 Increasing use of robotics and 3D printing in orthopedics
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Dearth of orthopedic surgeons
• 5.3 ECOSYSTEM ANALYSIS
• 5.4 SUPPLY CHAIN ANALYSIS
  • 5.4.1 MANUFACTURERS
    • 5.4.1.1 Prominent companies
    • 5.4.1.2 Small and medium-sized enterprises
  • 5.4.2 END USERS
• 5.5 VALUE CHAIN ANALYSIS
  • 5.5.1 RESEARCH AND DEVELOPMENT
  • 5.5.2 PROCUREMENT AND PRODUCT DEVELOPMENT
  • 5.5.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
• 5.6 TECHNOLOGY ANALYSIS
  • 5.6.1 KEY TECHNOLOGIES
    • 5.6.1.1 Robotic-assisted technology
  • 5.6.2 COMPLEMENTARY TECHNOLOGIES
    • 5.6.2.1 Imaging systems and software
    • 5.6.2.2 Fluoroscopy
  • 5.6.3 ADJACENT TECHNOLOGIES
    • 5.6.3.1 AI and machine learning
• 5.7 KEY CONFERENCES AND EVENTS IN 2025-2026
• 5.8 TRADE ANALYSIS
  • 5.8.1 IMPORT DATA FOR HS CODE 902110
  • 5.8.2 EXPORT DATA FOR HS CODE 902110
• 5.9 PATENT ANALYSIS
• 5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.11 PORTER'S FIVE FORCES ANALYSIS
  • 5.11.1 OVERVIEW
  • 5.11.2 THREAT OF NEW ENTRANTS
  • 5.11.3 THREAT OF SUBSTITUTES
  • 5.11.4 BARGAINING POWER OF SUPPLIERS
  • 5.11.5 BARGAINING POWER OF BUYERS
  • 5.11.6 INTENSITY OF COMPETITIVE RIVALRY
• 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS
  • 5.12.2 KEY BUYING CRITERIA
• 5.13 CASE STUDY ANALYSIS
  • 5.13.1 CASE STUDY 1: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND CHONDROPLASTY OF KNEE
  • 5.13.2 CASE STUDY 2: EFFECTIVENESS OF OSTEOPATHY IN TREATING SPORTS INJURIES
  • 5.13.3 CASE STUDY 3: TOTAL HIP REPLACEMENT WITH AVASCULAR NECROSIS
• 5.14 PRICING ANALYSIS
  • 5.14.1 AVERAGE SELLING PRICE, BY REGION
  • 5.14.2 AVERAGE SELLING PRICE, BY KEY PLAYER
• 5.15 REIMBURSEMENT SCENARIO
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 UNMET NEEDS AND KEY PAIN POINTS
• 5.18 REGULATORY LANDSCAPE
  • 5.18.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.18.2 REGULATORY FRAMEWORK
    • 5.18.2.1 North America
      • 5.18.2.1.1 US
      • 5.18.2.1.2 Canada
    • 5.18.2.2 Europe
    • 5.18.2.3 Asia Pacific
      • 5.18.2.3.1 Japan
      • 5.18.2.3.2 China
      • 5.18.2.3.3 India
• 5.19 IMPACT OF AI ON ORTHOPEDIC DEVICES MARKET
• 5.20 ADVANCED PROSTHETICS
• 5.21 SMART IMPLANTS

6 ORTHOPEDIC DEVICES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 ORTHOPEDIC REPLACEMENT DEVICES
  • 6.2.1 FOOT & ANKLE REPLACEMENT DEVICES
    • 6.2.1.1 Growing number of foot and ankle replacement procedures to fuel market growth
  • 6.2.2 KNEE REPLACEMENT DEVICES
    • 6.2.2.1 Ongoing innovation in knee implants to support growth
  • 6.2.3 HIP REPLACEMENT DEVICES
    • 6.2.3.1 Rising number of hip fractures and increasing success rate of hip arthroplasty to support market growth
  • 6.2.4 HAND & WRIST REPLACEMENT DEVICES
    • 6.2.4.1 Rising demand to support market growth
  • 6.2.5 ELBOW REPLACEMENT DEVICES
    • 6.2.5.1 Increasing frequency of elbow joint fractures and growth in elderly population to drive market
  • 6.2.6 SHOULDER REPLACEMENT DEVICES
    • 6.2.6.1 Launch of new shoulder replacement implants and rising popularity of reverse shoulder arthroplasty to support growth
  • 6.2.7 OTHER REPLACEMENT DEVICES
• 6.3 SPINAL IMPLANTS & SURGICAL DEVICES
  • 6.3.1 SPINAL FUSION DEVICES
    • 6.3.1.1 Advantages of anterior thoracic & anterior lumbar fusion to support market growth
  • 6.3.2 SPINAL NON-FUSION DEVICES
    • 6.3.2.1 Increasing incidence of degenerative diseases in younger populations to drive market
• 6.4 ORTHOPEDIC FIXATION DEVICES
  • 6.4.1 INTERNAL FIXATION DEVICES
    • 6.4.1.1 Reduced incidence of malunion or nonunion of injured bones to support adoption
  • 6.4.2 EXTERNAL FIXATION DEVICES
    • 6.4.2.1 Increasing incidence of upper and lower-extremity injuries to drive market
• 6.5 ARTHROSCOPY INSTRUMENTS
  • 6.5.1 RISING ARTHROSCOPY TREATMENT PROCEDURES TO SUPPORT MARKET GROWTH
• 6.6 ORTHOPEDIC BRACES & SUPPORTS
  • 6.6.1 KNEE BRACES & SUPPORTS
    • 6.6.1.1 Growing geriatric and obese populations to support market growth
  • 6.6.2 ANKLE BRACES & SUPPORTS
    • 6.6.2.1 Clinical benefits and favorable recommendations from physicians to support market growth
  • 6.6.3 FOOT WALKERS & ORTHOSES
    • 6.6.3.1 Rapidly growing diabetic population and subsequent rise in prevalence of foot problems to drive market
  • 6.6.4 BACK, HIP, AND SPINE BRACES & SUPPORTS
    • 6.6.4.1 Rising incidence of lower spine disorders to propel market
  • 6.6.5 SHOULDER BRACES & SUPPORTS
    • 6.6.5.1 Rising prevalence of shoulder arthritis to support market growth
  • 6.6.6 ELBOW BRACES & SUPPORTS
    • 6.6.6.1 Rising prevalence of elbow-related osteoarthritis to drive adoption
  • 6.6.7 HAND & WRIST BRACES & SUPPORTS
    • 6.6.7.1 Increasing incidence of hand and wrist injuries to drive market
  • 6.6.8 FACIAL BRACES & SUPPORTS
    • 6.6.8.1 Rising number of plastic surgeries to propel market
• 6.7 ORTHOPEDIC PROSTHETICS
  • 6.7.1 SOLID ANKLE CUSHION HEEL PROSTHESES
    • 6.7.1.1 Inexpensive, durable, and virtually maintenance-free properties to boost adoption
  • 6.7.2 SINGLE-AXIAL PROSTHESES
    • 6.7.2.1 Need for periodic servicing to limit adoption
  • 6.7.3 MULTI-AXIAL PROSTHESES
    • 6.7.3.1 High cost of multi-axial prostheses to limit market growth
  • 6.7.4 DYNAMIC RESPONSE PROSTHESES
    • 6.7.4.1 Low weight and support for active lifestyles to drive adoption
  • 6.7.5 MICROPROCESSOR-CONTROLLED PROSTHESES
    • 6.7.5.1 Higher stability and motion to support market growth
• 6.8 BONE GRAFT SUBSTITUTES
  • 6.8.1 AUTOGRAFTS
    • 6.8.1.1 High success rate in anterior and posterior cervical arthrodesis to support growth
  • 6.8.2 ALLOGRAFTS
    • 6.8.2.1 Reduced post-operative hospital stay coupled with limited requirement of incisions to drive market growth
  • 6.8.3 SYNTHETIC GRAFTS
    • 6.8.3.1 Reduced risk of disease transmission and high degree of customization to support market growth
• 6.9 ORTHOBIOLOGICS
  • 6.9.1 VISCOSUPPLEMENTATION PRODUCTS
    • 6.9.1.1 Cost-effectiveness of products to support market growth
  • 6.9.2 DEMINERALIZED BONE MATRIX
    • 6.9.2.1 Widespread acceptance in orthopedic surgery to fuel market growth
  • 6.9.3 BONE MORPHOGENETIC PROTEINS
    • 6.9.3.1 Osteoinductive properties and better integration in joint procedures to fuel market growth
  • 6.9.4 PLASMA-RICH PROTEIN
    • 6.9.4.1 Rising application of PRP in sports injuries to support market growth
  • 6.9.5 BONE MARROW ASPIRATE CONCENTRATE
    • 6.9.5.1 Minimally invasiveness procedure and less downtime to propel growth

7 ORTHOPEDIC DEVICES MARKET, BY PROCEDURE (VOLUME)

• 7.1 JOINT REPLACEMENT SURGERY PROCEDURAL VOLUME, BY SITE
• 7.2 ARTHROSCOPY PROCEDURAL VOLUME, BY SITE

8 ORTHOPEDIC DEVICES MARKET, BY SITE

• 8.1 INTRODUCTION
• 8.2 HAND & WRIST
  • 8.2.1 RISING CASES OF RADIUS AND ULNA FRACTURES TO SUPPORT MARKET GROWTH
• 8.3 SPINE
  • 8.3.1 TECHNOLOGICAL INNOVATIONS IN SPINAL IMPLANTS AND HIGHER INCIDENCE OF SPINAL SURGERY TO FUEL MARKET GROWTH
• 8.4 FOOT & ANKLE
  • 8.4.1 RISING PREFERENCE FOR FOOT & ANKLE RECONSTRUCTION TO AUGMENT GROWTH
• 8.5 ARM & ELBOW
  • 8.5.1 RISING INCIDENCE OF ARM FRACTURES TO ACCELERATE DEMAND FOR ORTHOPEDIC DEVICES
• 8.6 KNEE & THIGH
  • 8.6.1 GROWING CASES OF COLLATERAL LIGAMENT INJURIES AND TENDON TEARS TO FUEL MARKET
• 8.7 HIP & PELVIS
  • 8.7.1 RISING NUMBER OF PATIENTS UNDERGOING HIP REPLACEMENT SURGERY TO SUPPORT GROWTH
• 8.8 SHOULDER
  • 8.8.1 INCREASING INCIDENCE OF SHOULDER INJURIES TO DRIVE MARKET
• 8.9 CRANIOMAXILLOFACIAL
  • 8.9.1 INCREASING AWARENESS OF CRANIOMAXILLOFACIAL RECONSTRUCTIVE SURGERY TO PROPEL MARKET

9 ORTHOPEDIC DEVICES MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 FRACTURE TREATMENT & RECOVERY
  • 9.2.1 RISING INCIDENCE OF FRACTURES TO BOOST DEMAND FOR ORTHOPEDIC DEVICES
• 9.3 SPINAL FUSION, FIXATION, AND DECOMPRESSION
  • 9.3.1 GROWTH IN SPINAL FUSION SURGERIES TO DRIVE MARKET
• 9.4 RHEUMATOID ARTHRITIS & OSTEOARTHRITIS
  • 9.4.1 RISING POOL OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS TO DRIVE MARKET
• 9.5 LIGAMENT INJURIES
  • 9.5.1 INCREASING PARTICIPATION IN SPORTS AND PHYSICAL ACTIVITIES TO SUPPORT MARKET GROWTH
• 9.6 DIABETIC FOOT DISEASES
  • 9.6.1 GROWING PREVALENCE OF DIABETIC FOOT ULCERS TO SUPPORT MARKET GROWTH
• 9.7 NEUROLOGICAL DISORDERS
  • 9.7.1 RISING INCIDENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET

10 ORTHOPEDIC DEVICES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS & SURGICAL CENTERS
  • 10.2.1 RISING NUMBER OF ORTHOPEDIC SURGERIES COUPLED WITH INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET
• 10.3 AMBULATORY CARE CENTERS & TRAUMA UNITS
  • 10.3.1 COST-EFFECTIVE TREATMENT OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH
• 10.4 ORTHOPEDIC CLINICS
  • 10.4.1 INCREASING NUMBER OF ORTHOPEDIC CLINICS TO SUPPORT MARKET GROWTH
• 10.5 HOME CARE SETTINGS
  • 10.5.1 RISING PREFERENCE FOR HOME CARE TO SUSTAIN MARKET GROWTH
• 10.6 OTHER END USERS

11 ORTHOPEDIC DEVICES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 US to dominate North American market
  • 11.2.3 CANADA
    • 11.2.3.1 Rising incidence of degenerative bone diseases to support market growth
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Germany to account for largest market share in Europe
  • 11.3.3 FRANCE
    • 11.3.3.1 Increasing prevalence of musculoskeletal disorders and significant adoption of orthopedic devices to support market growth
  • 11.3.4 UK
    • 11.3.4.1 Increasing awareness of orthopedic conditions to drive adoption of innovative treatments
  • 11.3.5 ITALY
    • 11.3.5.1 Increasing awareness of preventive care for musculoskeletal injuries to drive market
  • 11.3.6 SPAIN
    • 11.3.6.1 Growing preference for minimally invasive surgical procedures to drive market
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Rapidly growing geriatric population to propel market
  • 11.4.3 CHINA
    • 11.4.3.1 Expanding target patient population to drive market
  • 11.4.4 INDIA
    • 11.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth
  • 11.4.5 AUSTRALIA
    • 11.4.5.1 Favorable government and private initiatives to promote market growth
  • 11.4.6 SOUTH KOREA
    • 11.4.6.1 Rising R&D and funding to drive market
  • 11.4.7 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Strong presence of global players to drive market
  • 11.5.3 MEXICO
    • 11.5.3.1 Favorable investment scenario for medical device manufacturers to support market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Growing public-private partnerships to propel the market growth
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2024)
  • 12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.4.1 RANKING OF KEY MARKET PLAYERS
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Product footprint
    • 12.5.5.4 Application footprint
    • 12.5.5.5 Site footprint
    • 12.5.5.6 End-user footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.6.5.1 Detailed list of key startups/SMEs
    • 12.6.5.2 Competitive benchmarking of key startups/SMEs
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 COMPANY VALUATION
  • 12.7.2 FINANCIAL METRICS
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES & APPROVALS
  • 12.9.2 DEALS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 ZIMMER BIOMET
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product approvals
      • 13.1.1.3.2 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 STRYKER
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 JOHNSON & JOHNSON MEDTECH
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches & approvals
      • 13.1.3.3.2 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 SMITH+NEPHEW
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches & approvals
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Expansions
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 B. BRAUN MELSUNGEN AG
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Key strengths
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses and competitive threats
  • 13.1.6 GLOBUS MEDICAL
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches & approvals
      • 13.1.6.3.2 Deals
  • 13.1.7 ARTHREX, INC.
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product approvals
  • 13.1.8 ENOVIS
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches & approvals
      • 13.1.8.3.2 Deals
      • 13.1.8.3.3 Expansions
  • 13.1.9 ACUMED LLC
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches
      • 13.1.9.3.2 Deals
      • 13.1.9.3.3 Expansions
  • 13.1.10 ORTHOFIX MEDICAL INC.
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product launches & approvals
      • 13.1.10.3.2 Deals
  • 13.1.11 MICROPORT SCIENTIFIC CORPORATION
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product launches & approvals
      • 13.1.11.3.2 Deals
  • 13.1.12 CONMED CORPORATION
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Deals
  • 13.1.13 PARAGON 28, INC.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Product launches & approvals
      • 13.1.13.3.2 Deals
  • 13.1.14 MEDACTA INTERNATIONAL
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Product launches & approvals
      • 13.1.14.3.2 Deals
      • 13.1.14.3.3 Expansions
  • 13.1.15 MERIL LIFE SCIENCES PVT. LTD.
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Expansions
  • 13.1.16 MAXX ORTHOPEDICS, INC.
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products offered
    • 13.1.16.3 Recent developments
      • 13.1.16.3.1 Product approvals
      • 13.1.16.3.2 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 FH ORTHO
  • 13.2.2 SYMBIOS ORTHOPEDIE S.A.
  • 13.2.3 MADISON ORTHO
  • 13.2.4 GREEN SURGICALS PVT. LTD.
  • 13.2.5 SIORA SURGICAL PVT. LTD.
  • 13.2.6 ORTHOPEDIATRICS CORP.
  • 13.2.7 RESTOR3D
  • 13.2.8 DOUBLE MEDICAL TECHNOLOGY INC.
  • 13.2.9 TREACE MEDICAL CONCEPTS, INC.
  • 13.2.10 AK MEDICAL

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS